Is Anthera Pharmaceuticals, Inc. (ANTH) a Buy, Sell, or Hold?
OTC : ANTH
Anthera Pharmaceuticals, Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 23.89K
- Average Volume
- 2.26K
- Market Capitalization
- $2.62K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.68
Company Overview
OTC
Paul F. Truex
Biotechnology
Healthcare
ANTH
21
US
USD
Liquidity Metrics
0.00
0.68
0.68
0.47
0.00
Sales & Valuation
-$
0.00
0.00
0.00
-3.59
Profitability
-$1.65
-$16.94M
0.00%
0.00%
-485.59%
-461.07%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
12 Analysts
%
Financial Health Scores
-83.35
0/9
$6.09M
$8.81M
$3.35M
-$37.18M
Key Metrics (TTM)
-$2.19M
0.00
0.08
0.68
-485.59%
3509.83%
-1647631.42%
-1409472.88%
-2380 days
Company Executives
| Name | Title |
|---|---|
| Paul F. Truex | Executive Chairman |
| May Liu | Senior Vice President of Finance & Administration and Principal Accounting Officer |
| Paul Adams | Senior Vice President of Global Regulatory Affairs and Compliance |
| Joshua Caldwell | Chief Liquidating Officer |
Poll Results
No votes yet today — be the first to share your view!
About Anthera Pharmaceuticals, Inc. (OTC:ANTH) Stock
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas. ...
AMD and Cerbras Create A New Blueprint For Hardware
2026-07-24 12:10:26
Artificial intelligence (AI) infrastructure is hitting a physical wall. As large language models grow exponentially in size, the legacy approach of throwing large, monolithic graphics processing units at the problem breaks down during the inference phase.
SpaceX Lost $1 Trillion In A Week. So Why Did Bond Investors Rush To Lend It $20 Billion?
2026-06-23 08:43:40
Space Exploration Technologies Corp. (NASDAQ:SPCX) has lost more than $1 trillion in market value since reaching a roughly $3 trillion valuation last week. At first glance, that sounds like a company in trouble.
Frequently Asked Questions
-
What is the current Anthera Pharmaceuticals, Inc. (ANTH) stock price?
-
Anthera Pharmaceuticals, Inc.(OTC:ANTH) stock price is $0.0001 in the last trading session. During the trading session, ANTH stock reached the peak price of $0.001 while $0.0001 was the lowest point it dropped to. The percentage change in ANTH stock occurred in the recent session was 0.0% while the dollar amount for the price change in ANTH stock was $0.
-
ANTH's industry and sector of operation?
-
The OTC listed ANTH is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ANTH?
-
Paul F. Truex | Executive Chairman
May Liu | Senior Vice President of Finance & Administration and Principal Accounting Officer
Paul Adams | Senior Vice President of Global Regulatory Affairs and Compliance
Joshua Caldwell | Chief Liquidating Officer
| -
How many employees does ANTH have?
-
Number of ANTH employees currently stands at 21. ANTH operates from The Pennzoil Building, Houston, TX 77002, US.
-
Link for ANTH official website?
-
Official Website of ANTH is: https://www.anthera.com
-
How do I contact ANTH?
-
ANTH could be contacted at phone #410 350 1839 and can also be accessed through its website. ANTH operates from The Pennzoil Building, Houston, TX 77002, US.
-
How many shares of ANTH are traded daily?
-
The average number of ANTH shares traded daily for last 3 months was 2.26K.
-
What is the market cap of ANTH currently?
-
The market value of ANTH currently stands at $2.62K with its latest stock price at $0.0001